Patents by Inventor David Pribnow

David Pribnow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systematic polypeptide evolution by reverse translation
    Publication number: 20020038000
    Abstract: A method for preparing polypeptide ligands of target molecules wherein candidate mixtures comprised of ribosome complexes or mRNA&Circlesolid;polypeptide copolymers are partitioned relative to their affinity to the target and amplified to create a new candidate mixture enriched in ribosome complexes or mRNA&Circlesolid;polypeptide copolymers with an affinity to the target.
    Type: Application
    Filed: February 22, 2001
    Publication date: March 28, 2002
    Inventors: Larry Gold, Craig Tuerk, David Pribnow, Jonathan Drew Smith
  • Systematic polypeptide evolution by reverse translation
    Patent number: 6194550
    Abstract: A method for preparing polypeptide ligands of target molecules wherein candidate mixtures comprised of ribosome complexes or mRNA•polypeptide copolymers are partitioned relative to their affinity to the target and amplified to create a new candidate mixture enriched in ribosome complexes or mRNA•polypeptide copolymers with an affinity to the target.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: February 27, 2001
    Inventors: Larry Gold, Craig Tuerk, David Pribnow, Jonathan Drew Smith
  • Systematic polypeptide evolution by reverse translation
    Patent number: 5843701
    Abstract: A method for preparing polypeptide ligands of target molecules wherein candidate mixtures comprised of ribosome complexes or mRNA.multidot.polypeptide copolymers are partitioned relative to their affinity to the target and amplified to create a new candidate mixture enriched in ribosome complexes or mRNA.multidot.polypeptide copolymers with an affinity to the target.
    Type: Grant
    Filed: January 31, 1992
    Date of Patent: December 1, 1998
    Assignee: NeXstar Pharmaceticals, Inc.
    Inventors: Larry Gold, Craig Tuerk, David Pribnow, Jonathan Drew Smith